Dr. Richard Moerschell received a Ph.D. in Biophysics from the University of Rochester in Rochester, NY. During the course of his studies he developed the technique for transforming yeast directly with synthetic oligonucleotides. In his studies, he has determined the specificity of methionine aminopeptidase and co-discovered the first N-terminal acetyltransferase. He went on to post-doctoral positions at Osaka University and Harvard Medical School where he studied ATP dependent proteases and chaperones. He has over 15 years experience in the life science industry in roles marketing and R&D. Dr. Moerschell is registered to practice as a patent agent with the US Patent Office. www.molecularpurity.com